-
Product Name
MYEOV antibody
- Documents
-
Description
MYEOV Rabbit Polyclonal antibody. Positive IHC detected in human ovary tumor tissue. Positive WB detected in SGC-7901 cells, Jurkat cells. Observed molecular weight by Western-blot: 55-60 kDa
-
Tested applications
ELISA, WB, IHC
-
Species reactivity
Human; other species not tested.
-
Alternative names
MYEOV antibody; OCIM antibody; Oncogene in multiple myeloma antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of MYEOV recombinant protein (Accession Number: XM_047426763). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:200-1:2000
IHC: 1:20-1:200
-
Validations
SGC-7901 cells were subjected to SDS PAGE followed by western blot with Catalog No:112924(MYEOV antibody) at dilution of 1:400
Immunohistochemical of paraffin-embedded human ovary tumor using Catalog No:112924(MYEOV antibody) at dilution of 1:50 (under 10x lens)
-
Background
MYEOV, also named as ocIM, was originally isolated by the application of the NIH/3T3 tumorigenicity assay with DNA from a gastric carcinoma. It is a prognostic factor for patients with multiple myeloma, in part through a role of MYEOV in the control of MMC proliferation. MYEOV is a candidate oncogene activated in the amplification core located proximal tocCND1.
-
References
- Moreaux J, Hose D, Bonnefond A. MYEOV is a prognostic factor in multiple myeloma. Experimental hematology. 38(12):1189-1198.e3. 2010.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"